MYC and cancer: Our results with DON support mounting evidence in the cancer metabolism field that targeting glutamine metabolism is a promising therapeutic strategy for Myc-overexpressing cancers, and identifying other inhibitors of glutamine metabolism could yield promising new therapies for pediatric patients.